Marla Persky is CEO and President of WOMN LLC, a company dedicated to helping women succeed in the business of law by increasing their knowledge of and acuity with financial drivers, client development, and leadership. Marla retired in 2014 as Senior Vice President, General Counsel and Corporate Secretary for Boehringer Ingelheim Inc. She was a member of Boehringer’s executive management team and a director of the company and several of its subsidiaries. Prior to joining Boehringer Ingelheim, Marla spent 19 years at Baxter International Inc. where she held numerous business and legal positions, the most recent of which was Acting General Counsel and Corporate Secretary. Marla currently serves Chairperson of the Board of Directors and is a member of the Audit and Governance Committees of Xeris Biopharma Holdings, Inc. (NASDAQ: XERS), a biopharmaceutical company developing and commercializing unique therapies for patient populations in endocrinology, neurology, and gastroenterology. Additionally, she is on the Board of Directors of REVOLO Biotherapeutics which develops therapies to reset the immune system to achieve long-term remission for patients with autoimmune and allergic diseases. Ms. Persky also serves on the Audit and Strategic Planning Committees of the Board of Directors of YGEIA, a medical informatics technology company. Previously, she served on the Board of Directors of Cytyc Corporation (NASDAQ: CYTYC) a device and diagnostics company specializing in women’s health. In addition to her corporate activities, Ms. Persky is on the Board of several not-for-profit organizations such as the Leukemia & Lymphoma Society, and Primary Stages (Off-Broadway Theater Company). Ms. Persky received her JD from Washington University School of Law and her BS from Northwestern University.